Department of Rehabilitation, CRRF "Mons. Luigi Novarese", Moncrivello, Italy.
Scientific Research Area, Italian Multiple Sclerosis Foundation, Genoa, Italy.
Eur J Neurol. 2023 Jan;30(1):172-178. doi: 10.1111/ene.15560. Epub 2022 Sep 28.
Upper limb (UL) function is often affected in people with multiple sclerosis (PwMS) and is typically assessed through objective measures, including the Nine Hole Peg Test (9-HPT), Box and Block Test (BBT), and Hand Grip Strength (HGS). It is important to include the subjective perspective of PwMS in the assessment. This study aims to evaluate associations between Manual Ability Measure-36 (MAM-36) and 9-HPT, BBT, and HGS in MS.
The cross-sectional study included five Italian centers. Inclusion criteria were age ≥ 18 years, MS diagnosis, and stable disease course. Exclusion criteria were bilateral UL paralysis, and concomitant orthopedic or neurological diseases.
A total of 199 PwMS were included: 128 female, mean age = 50.7 ± 13.0 years, 119 relapsing-remitting MS (RRMS), 31 primary and 49 secondary progressive MS, mean disease duration = 14.0 ± 10.4, years, mean Expanded Disability Status Scale (EDSS) = 4.6 ± 2.0. The MAM-36 showed small correlations with 9-HPT, BBT, and HGS. Correlations between MAM-36 and 9-HPT and BBT were highest among subjects with EDSS ≥ 6 and progressive MS. MAM-36 and HGS showed the highest correlations in subjects with EDSS ≤ 5 and RRMS. Combining 9-HPT and HGS provided the strongest predictive power over the MAM-36.
Correlations between objective measures and MAM-36 were small to moderate, meaning that objective measures do not match subjects' perception of UL function. The combination of 9-HPT and HGS measures can help improve the assessment of UL function in activities of daily living.
上肢(UL)功能在多发性硬化症(PwMS)患者中常受到影响,通常通过客观测量进行评估,包括九孔钉测试(9-HPT)、箱和块测试(BBT)和握力(HGS)。重要的是要将 PwMS 的主观观点纳入评估中。本研究旨在评估多发性硬化症患者的手动能力测量-36 (MAM-36)与 9-HPT、BBT 和 HGS 之间的相关性。
这项横断面研究包括五个意大利中心。纳入标准为年龄≥18 岁、多发性硬化症诊断和稳定的疾病过程。排除标准为双侧 UL 瘫痪和同时存在的骨科或神经科疾病。
共有 199 名 PwMS 纳入研究:128 名女性,平均年龄 50.7±13.0 岁,119 名复发缓解型多发性硬化症(RRMS),31 名原发性多发性硬化症和 49 名继发性进展型多发性硬化症,平均疾病病程 14.0±10.4 年,平均扩展残疾状态量表(EDSS)4.6±2.0。MAM-36 与 9-HPT、BBT 和 HGS 呈小相关。在 EDSS≥6 和进展型多发性硬化症患者中,MAM-36 与 9-HPT 和 BBT 的相关性最高。在 EDSS≤5 和 RRMS 患者中,MAM-36 和 HGS 的相关性最高。将 9-HPT 和 HGS 相结合提供了对 MAM-36 的最强预测能力。
客观测量与 MAM-36 之间的相关性为小至中度,这意味着客观测量与患者对上肢功能的感知不匹配。9-HPT 和 HGS 测量的结合可以帮助改善日常生活活动中对上肢功能的评估。